Hepatitis E in the Unites States - An NIH Research Workshop

AGENDA

Organizers:

Kenrad Nelson, M.D.; Rajen Koshy, Ph.D.; Robert H. Purcell, M.D.; Jay H. Hoofnagle, M.D.; and
Averell H. Sherker, M.D., FRCP(C)

7:30 – 8:30 a.m.

Registration

8:30 – 8:40 a.m.

Welcome and Aims
Jay H. Hoofnagle, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

            
            Session  1:

              Moderators:  
            The Hepatitis E Virus (HEV)

            Rajen Koshy, Ph.D., National Institute of  Allergy and Infectious Diseases (NIAID)

                Robert H. Purcell, M.D., NIAID

8:40 – 9:00 a.m.

Molecular Virology of HEV
Sue Emerson, Ph.D., NIAID

9:00 – 9:20 a.m.

Diagnostic Assays for HEV
Harry Dalton, MBBS, DPhil, Royal Cornwall Hospital Trust and Peninsula College of Medicine and Dentistry (United Kingdom)

9:20 – 9:40 a.m.

HEV as a Zoonosis
Xiang-Jin Meng, M.D., Ph.D., Virginia Polytechnic Institute and State University

9:40 – 10:10 a.m.

Discussion
Moderators and Speakers

10:10 – 10:30 a.m.

Break

            
            Session 2:

              Moderators:  
            Epidemiology  of Hepatitis E

            Jay H. Hoofnagle, M.D., NIDDK

            Harry  Dalton, MBBS, DPhil, Royal Cornwall Hospital Trust and Peninsula  College of Medicine and Dentistry

10:30 – 10:50 a.m.

Epidemiology in Asia
Alain Labrique, Ph.D., M.H.S., Johns Hopkins University

10:50 – 11:10 a.m.

Epidemiology in Europe
Philippe Colson, M.D., Centre Hospitalo-Universitaire Timone (France)

11:10 – 11:30 a.m.

Epidemiology in the United States
Kenrad Nelson, M.D., Johns Hopkins University

11:30 – 11:50 a.m.

Hepatitis E in the United States
Scott Holmberg, M.D., Centers for Disease Control and Prevention (CDC)

11:50 a.m. – 12:20 p.m.

Discussion
Moderators and Speakers

12:20 – 1:30 p.m.

Lunch and Posters

            
                    Session 3:

                      Moderators:  
                    Special  Populations

                    Kenrad Nelson, M.D., Johns Hopkins  University

                    Averell H. Sherker, M.D., FRCP(C), NIDDK

1:30 – 1:50 p.m.

Clinical Course and Complications
Jay H. Hoofnagle, M.D., NIDDK

1:50 – 2:10 p.m.

HEV and Acute Liver Failure
Robert Fontana, M.D., University of Michigan

2:10 – 2:30 p.m.

HEV After Organ Transplantation
Norah Terrault, M.D., M.P.H., University of California, San Francisco

2:30 – 2:50 p.m.

HEV and HIV Co-infection
Caryn Morse, M.D., M.P.H., Warren G. Magnuson Clinical Center (CC), National Institutes of Health (NIH)

2:50 – 3:20 p.m.

Discussion
Moderators and Speakers

3:20 – 3:40 p.m.

Break

            
                    Session 4:

                      Moderators:  
                    Treatment  and Prevention

                    Sally Hojvat, U.S. Food and Drug Administration (FDA)

                    John  Ward, M.D., CDC

3:40 – 4:00 p.m.

HEV Screening in Blood Donors
Chenyu Xu, Ph.D., CC, NIH

4:00 – 4:20 p.m.

HEV and Food Safety Issues
Julie Ann Kase, Ph.D., FDA

4:20 – 4:40 p.m.

HEV Vaccines
James Wai Kuo Shih, Ph.D., Xiamen University (China)

4:40 – 5:00 p.m.

Treatment of HEV
Nassim Kamar, M.D., Center Hospitalier Universitaire Rangueil (France)

5:00 – 5:30 p.m.

Discussion of Future Needs
Moderators and Speakers

5:30 p.m.

Adjournment